Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00419913 · ClinicalTrials.gov registry record · Phase 2
A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)
A Phase 2 study, sponsored by Center for Human Reproduction.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00419913 is a Phase 2 study that was terminated before completion, run by Center for Human Reproduction. The registered enrollment target is 8 participants.
The verdict
NCT00419913, a Phase 2 study, was terminated before completion, sponsored by Center for Human Reproduction.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
Our long term goal is to elucidate the role of DHEA on follicular dynamics in the human ovary and to better understand the interaction of DHEA supplementation with other treatments for ovulation induction, especially among older reproductive age women. The specific hypothesis behind the proposed research is that DHEA is a regulator of follicular dynamics acting in the early pre-gonadotropin dependent stage of initial primordial follicle recruitment and growth.
Interventions
- DIETARY_SUPPLEMENT Dehydroepiandrosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00419913
The ClinicalTrials.gov registry entry for NCT00419913 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Human Reproduction, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dehydroepiandrosterone is the first listed.
NCT00419913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00419913 about?
NCT00419913 is a clinical study titled "A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)". Our long term goal is to elucidate the role of DHEA on follicular dynamics in the human ovary and to better understand the interaction of DHEA supplementation with other treatments for ovulation induction, especially among older reproductive age women. The specific hypothesis behind the proposed re...
What is the current status of trial NCT00419913?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2007-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00419913?
The interventions under investigation include: Dehydroepiandrosterone (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00419913?
This trial is sponsored by Center for Human Reproduction, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.